Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Congenital structural myopathy
Myofibrillar myopathy
Myofibrillar myopathy (MFM) describes a group of skeletal and cardiac muscle disorders, defined by the disintegration of myofibrils and aggregation of degradation products into intracellular inclusions, and is typically clinically characterized by slowly-progressive muscle weakness, which initially involves the distal muscles, but is highly variable and that can affect the proximal muscles as well as the cardiac and respiratory muscles in some patients.
-
Central core myopathy 2 trials
-
Myofibrillar myopathy 1 0 trials
-
Myofibrillar myopathy 10 0 trials
-
Myofibrillar myopathy 11 0 trials
-
Myofibrillar myopathy 3 0 trials
-
Myofibrillar myopathy 4 0 trials
-
Myofibrillar myopathy 5 0 trials
-
Myofibrillar myopathy 6 0 trials
-
Myofibrillar myopathy 7 0 trials Sub-types →
-
Myofibrillar myopathy 8 0 trials